In the Internet field, China and the United States can go hand in hand, and in the field of mobile medical / digital medical care , the gap between China and the United States is still relatively large. For example, there are no fewer than 10 listed companies in the US (such as Athena Health, Epocrates, Castlight); there is no one in China.
What are the important differences between China and the United States in this field?
First, the core user
On the user side, most mobile medical companies in China regard patients or healthy people as the center of their business; in the United States, it is possible to serve patients, doctors and hospitals in three ways. The main bottleneck of China's medical care is that it is difficult for patients to obtain high-quality medical services, so many companies trying to get through this "way" through the Internet. In the United States, it is not difficult for patients to receive medical services. The main problem is high cost and inefficiency. For doctors and hospitals in the United States, how to improve efficiency, reduce waste, and improve medical quality is just a matter of necessity. There are many companies that serve it.
Second, the value proposition
In China, mobile medical companies love to adopt a “platform modelâ€, which is to build a platform to build a bridge between patients, doctors, and hospitals, and to become a “drip and drip†between doctors, patients, or hospitals. Information asymmetry and medical difficulties. In the United States, cloud computing and big data technologies are increasingly used to improve the quality of medical services. For example, in 2014, several medical Internet companies with the highest financing in the United States had this feature, such as NantHealth ($135 million), Flatiron Health ($130 million), and Alignment HealthCare ($125 million). In general, China and the United States are at different stages of the development of the medical system: China is more focused on providing medical care, while the United States is focused on improving medical quality and controlling costs.
Third, the value chain
In almost every country in the world, the value chain of medical services is very long. Whether there is good integration and interaction in the upper, middle and lower reaches of the value chain is the key to the realization of the mobile medical business model.
In China, the value chain involved in the value chain of medical services is very fragmented, and many value transmissions are still under the table, lacking a good means of information interaction. The United States has basically achieved end-to-end integration, such as the cloud electronic medical record service provider, Practice Fusion, which provides integration from doctor referrals, online diagnostic reports, and prescriptions. Investigating the reasons behind it, the US medical service sector has a high degree of privatization, and the threshold for entry is low. Therefore, third-party service providers can flourish, and the Chinese medical system is owned by the government and is more dispersed. Therefore, it is difficult to integrate. . However, these differences have also become a unique opportunity for Chinese medical services and mobile medical entrepreneurship.
Fourth, technology
In terms of technology, Chinese startups mostly use existing mature technologies to migrate from other vertical fields to the medical industry . And more American companies are committed to real innovation in technology. For example, the aforementioned Nant Health, how to integrate various types of medical data (such as electronic medical records, genomic data, clinical trials), how to analyze these data in real time and provide feedback, and high-speed transmission of large data on mobile devices Data, there are many technical breakthroughs. In terms of innovation in this field, China's mobile medical companies still have a long way to go.
V. Business model
Related to the value chain of the Chinese and American healthcare systems, China Mobile's medical companies seem to have yet to find a mature and scalable business model. Many companies try to pay for patients directly, but the patient's willingness and ability to pay have yet to be verified. The E-marketing model of pharmaceutical companies also has ceilings. In the United States, insurance companies, pharmaceutical companies, hospitals, and doctors' clinics are all payers, and it is rare for patients to pay personally.
Sixth, data security and patient privacy protection
In the United States, protecting medical data security and patient privacy is a fundamental requirement for mobile healthcare companies. Many startups do so in accordance with the requirements of the Health Insurance Portability and Accountability Act (HIPAA). For example, the company set up a chief compliance officer, employees to conduct HIPAA training, encryption of privacy information and other operations. Because China's laws and regulations in this field are not perfect, enterprises pay less attention to this aspect.
Outlook
Due to differences in basic national conditions, social systems, user habits, and value chains, there are still major differences in the development stages of mobile medical care between China and the United States. Blindly copying US mobile medical products and services is likely to be “unacceptable†in China.
Many existing mobile medical products target customers to patients and work hard to bridge the gap. The author believes that in China, if you do not solve the problem of low quality doctors and low relative performance, no matter how the cake is cut, it will not be enough. In the market where the supply and demand of doctors and patients are seriously mismatched, doctor users are the most important source of resources and value for the mobile medical business. Cut into the market segment of doctors, provide mobile Internet solutions for doctors, help them improve efficiency, improve quality, increase output in patient medical services and other daily work, and improve service supply more effectively, and then serve more More patients.
Rice protein is a kind of complete protein, and rice protein peptide contains 18 kinds of essential amino acids. The absorption rate of rice protein peptide in human body is more than 98%, it can improve the immune function of human body, anti-fatigue, is conducive to the growth and development of children, especially can promote the intellectual development of children.
At the same time, the valley sterol contained in rice protein, can inhibit the role of cholesterol, the high content of cholesterol in the human body can play a role in regulation and balance.
Rice Peptides,Raw material Rice peptides,Pure Rice
KARAK , https://www.jskarak.com